<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Open Science Publishers LLP</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">214</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> https://doi.org/10.31782/IJMPS.2022.121001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Formulation Development and Characterization of Ointments containing Bambusa arundinacea Extract and Chlorophytum borivilianum Extract&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nandal</surname><given-names>Ritu</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>18</day><month>10</month><year>2022</year></pub-date><volume>0)</volume><issue/><fpage>1</fpage><lpage>5</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>The goal of the current study was to investigate potential applications for extracts of Bambusa arundinacea (resin) and Chlorophytum borivilianum (rhizome) used in ointment formulations. The pharmaceutical properties of the formulations, such as pH, the skin irritancy test, viscosity, appearance, extrudability, spreadability, washability, and swelling index, were evaluated. The skin irritation test inquiry found that no particular edema or erythema symptoms appeared after therapy for continuous seven days. pH measurements of the formulations were 6.3 (F1) and 6.7 (F2). While F2 showed edema of 1.29%, F1 showed swelling of 1.42%. The two ointment compositions__ampersandsignrsquo; respective spreadabilities were 6.5 g.cm/sec and 6.0 g.cm/sec. The formulae for F1 and F2 were found to be +++ and +++, respectively, extrudable from the collapsible tubes. In light of the formulations__ampersandsignrsquo; rheological characteristics, the viscosity was found to be 5300 cps (F1) and 6200 cps (F2). The washability of the formulations was found to be +++ for Formulation-1 and +++ for Formulation-2. By making this finding, which also revived the ideas of ethnopharmacology in connection to modern medicine, the uses of polyherbal formulations in conventional medicine were made clear.&#13;
</p></abstract><kwd-group><kwd> Extract</kwd><kwd> Ointment</kwd><kwd> Formulation</kwd><kwd> Characterization</kwd><kwd> Bambusa arundinacea</kwd><kwd> Chlorophytum borivilianum</kwd></kwd-group></article-meta></front></article>
